Due to system upgrades, please note the following. Orders can be placed in the online store but will be fulfilled after 7/14/2025. Learning activities ordered will be available immediately after order placement. CAP is committed to processing orders as quickly and securely as possible during this upgrade. Thank you for your patience.
Please log in to determine if you are eligible to purchase PT Programs.
HUMAN PAPILLOMAVIRUS, MIXED MEDIA - CHPVJ
CHPVJ
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Analyte/Procedure
Challenges per Shipment
Number of Shipments
HPV
5
Three shipments per year
High‑risk HPV genotyping (optional)
5
Additional Information
Each laboratory should choose the Survey that best reflects the transport media received in its facility. For Survey CHPVJ, participants must provide results for all three media types.
For laboratories that perform HPV genotyping using ThinPrep PreservCyt Transport medium on site, Survey CHPVM and select samples of Survey CHPVJ provide an opportunity to report specific HPV genotypes.
The CAP does not report genotyping responses to the CMS.
Program Information
Five simulated cervical specimens
Combination of Digene, ThinPrep PreservCyt, and SurePath transport mediums
Help